NCT04916678

Brief Summary

Promising results of an early EMDR (Eye Movement Desensitization and Reprocessing) intervention on PCLS (PostConcussion-Like Syndrome) at three months have been shown, suggesting that the availability of psychological care in emergency departments will be useful. The real impact of such a care service remains to be measured. Several factors may modulate the impact of such a measure, leaving the extent of its public health benefit uncertain. In the SOFTER III trial, the results suggest that high levels of self-rated stress at admission probably play a key role in the development of CPSP and psychological intervention. The most appropriate study design for such an objective is to follow a cohort of patients in the Emergency Department and to assess the main risk factors for CPSD 4 months later. To this end, all consecutive patients should be asked to participate in a study and complete a risk factor questionnaire, regardless of their level of risk for CPSD. SOFTER IV offers the opportunity to evaluate the impact of a psychological intervention to reduce the incidence of chronic pain. By acting on the emotions experienced in the Emergency Department, a reduction in acute pain and perhaps in the longer term in chronic pain can be expected. Its psychological aspects, and more specifically the emotional dimension, are known to be related to acute pain. As for the relationship with chronic pain, it exists, but its meaning is not clear because the emotional state is assessed when the pain has already become chronic. It is proposed to integrate the assessment of emotions at inclusion in the project, and to follow up patients 12 months after inclusion to assess the incidence of chronic pain and identify the factors that modulate it. Early intervention in the emergency department, including an early short one-hour EMDR intervention R-TEP (Recent Traumatic Episode Protocol), could thus reduce the incidence of chronic pain.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2,897

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Oct 2021

Geographic Reach
1 country

7 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 15, 2021

Completed
2 months until next milestone

First Posted

Study publicly available on registry

June 7, 2021

Completed
4 months until next milestone

Study Start

First participant enrolled

October 18, 2021

Completed
8 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 22, 2022

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

June 22, 2023

Completed
Last Updated

April 26, 2024

Status Verified

April 1, 2024

Enrollment Period

8 months

First QC Date

April 15, 2021

Last Update Submit

April 24, 2024

Conditions

Keywords

Persistent PostConcussion-Like SymptomsPost-Traumatic Stress DisorderEmergency RoomEMDR

Outcome Measures

Primary Outcomes (1)

  • Proportion of patients with PostConcussion-Like Syndrome (PCLS) at 4 months.

    Proportion of patients with PCLS at 4 months, measured with the Rivermead Postconcussion Symptoms Questionnaire. Each item (16) is rated on a 5-point ordinal scale : 0 = Not experienced at all to 4 = A severe problem. The total sore is a sum of all items and ranges from 0 to 64 (best to worst).

    4 months after inclusion day

Secondary Outcomes (7)

  • Proportion of patients with PTSD at 4-months

    4 months after inclusion day

  • Establishment of a PCLS Predictive factors list

    4 months after inclusion day

  • Assessment of health care consumption

    12 months after inclusion day

  • Proportion of patients with chronic pain

    12 months after inclusion day

  • Establishment of chronic pain predictive factors

    12 months after inclusion day

  • +2 more secondary outcomes

Study Arms (2)

Control

NO INTERVENTION

The control period is a 5-day period during which no psychologist is available. ER cares will be provided as usual.

Intervention

EXPERIMENTAL

The intervention period is a 5-day period during which trained psychologists are available in the ER and will provide a R-TEP EMDR intervention for patients selected with high risk of PCLS and who may provide psychotherapeutic care or reassurance to other patients should they be identified in need of help.

Other: R-TEP EMDR intervention

Interventions

During the intervention period, trained psychologists are available in the ER and will provide preferentially a short early 1-hour R-TEP EMDR intervention for patients selected with high risk of PCLS. Patient's selection will be conducted using a score developed in previous studies. If therapist considers R-TEP EMDR unsuitable, he could provide another type of intervention (such as reassurance) that will be recorded. When no high-risk patient is identified, the therapist could assess other patients and treat them if judged necessary. In this context, they could provide either a R-TEP EMDR or short intervention such as reassurance according to therapist assessment.

Intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 and more
  • Conscious, able to provide informed consent, able to understand study procedures and to comply with them for the entire length of the study. Speaking French.

You may not qualify if:

  • Current drug or alcohol use or dependence that, in the opinion of the site investigator, would interfere with adherence to study requirements.
  • Inability or unwillingness of individual or legal guardian/representative to give written informed consent.
  • Inability or unwillingness to be contacted for 4-month follow-up interview.
  • Pregnancy or breastfeeding.
  • Curatorship or guardianship.
  • Prisoners.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (7)

Hopital Pellegrin

Bordeaux, 33000, France

Location

Hôpital Beaujon

Clichy, 92110, France

Location

Hôpital Louis Mourier

Colombes, 92000, France

Location

CH de Libourne

Libourne, 33505, France

Location

Hôpital Edouard Herriot

Lyon, 69003, France

Location

Hôpital Lariboisière

Paris, 75010, France

Location

Hôpital Purpan

Toulouse, 31059, France

Location

Related Publications (1)

  • Tandzi Tonleu F, Pilet C, Lagarde E, Gil-Jardine C, Galinski M, Lafont S. Subjective risk factors of severe pain at discharge from the emergency department. Intern Emerg Med. 2025 Apr;20(3):899-907. doi: 10.1007/s11739-024-03730-4. Epub 2024 Aug 6.

MeSH Terms

Conditions

Stress Disorders, Post-TraumaticEmergencies

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental DisordersDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Emmanuel LAGARDE, Pr

    Bordeaux Population Health Research Center (Inserm U1219)

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: The study is a multi-site cluster randomized cross-over trial with two comparative groups. In each site, the control period and intervention period span over a period of 10 days (5 days for control and 5 days for intervention). The sequence of the control and intervention periods will be set at random.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 15, 2021

First Posted

June 7, 2021

Study Start

October 18, 2021

Primary Completion

June 22, 2022

Study Completion

June 22, 2023

Last Updated

April 26, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations